Loading...
E

Enfusion Inc
NYSE:ENFN

Watchlist Manager
Enfusion Inc
NYSE:ENFN
Watchlist
Price: 9.41 USD +1.62% Market Closed
Updated: Dec 10, 2022

Intrinsic Value

The intrinsic value of one ENFN stock under the Base Case scenario is 9.19 USD. Compared to the current market price of 9.41 USD, Enfusion Inc is Overvalued by 2%.

The Intrinsic Value is calculated as the average of the two valuation methods:

ENFN Intrinsic Value
Base Case
9.19 USD
Overvaluation 2%
Intrinsic Value
Price
E
Worst Case
Base Case
Best Case

Fundamental Analysis

ENFN Profitability Score
Profitability Due Diligence

Enfusion Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Negative 3-Year Average ROE
Negative 3-Year Average ROIC
Negative Free Cash Flow
Negative Operating Income
28/100
Profitability
Score

Enfusion Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

ENFN Solvency Score
Solvency Due Diligence

Enfusion Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low Interest Coverage
Low Altman Z-Score
Long-Term Liabilities
Short-Term Liabilities
45/100
Solvency
Score

Enfusion Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
69%
Gross Margin
-181%
Operating Margin
-113%
Net Margin
-4%
FCF Margin
-29 158%
ROE
-710%
ROIC
Other

ENFN Capital Structure
Enfusion Inc

Market Capitalization 630M USD
Total Debt 0 USD
Minority Interest 42M USD
Preferred Equity 0 USD
Cash and Equivalents 63.5M USD
Short-Term Investments 0 USD
Enterprise Value 609M USD

Wall St
Price Targets

ENFN Price Targets Summary
Enfusion Inc

Wall Street analysts forecast ENFN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENFN is 14.69 USD with a low forecast of 13.13 USD and a high forecast of 16.8 USD.

Lowest
Price Target
13.13 USD
40% Upside
Average
Price Target
14.69 USD
56% Upside
Highest
Price Target
16.8 USD
79% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

ENFN Competitors
Enfusion Inc

ENFN Suppliers & Customers
Enfusion Inc

Enfusion Inc has 2 key suppliers from 1 countries and 2 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Media industry.

Enfusion Inc has 2 key customers from 1 countries and 1 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Financial Services industry.

Ownership

ENFN Insider Trading
Buy and sell transactions by insiders

Enfusion Inc insiders have only sold shares in the past 12 months.

During the last 12 months Enfusion Inc insiders have not bought any shares, and sold 12.7M USD worth of shares. The last transaction was made on Dec 10, 2022 by Groman Dan (Chief Technology Officer), who sold 71.7k USD worth of ENFN shares.

Sold
0-3
months
12.7M USD
3
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
12.7M USD
N/A
-12.7M
6 Months
12.7M USD
N/A
-12.7M
9 Months
12.7M USD
N/A
-12.7M
12 Months
12.7M USD
N/A
-12.7M
Purchases
2
Sales
6
Why is insider trading important?

Shareholder Return

ENFN Price
Enfusion Inc

1M 1M
-28%
6M 6M
-7%
1Y 1Y
-49%
3Y 3Y
-52%
5Y 5Y
-52%
Annual Price Range
9.41
52w Low
8.4
52w High
21.44
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -63%
Shares Statistics
Market Capitalization 630M USD
Shares Outstanding 67 001 700
Percentage of Shares Shorted 6.41%

Company Profile

Enfusion Inc

Country

United States of America

Industry

Technology

Market Cap

630M USD

Dividend Yield

0%

Description

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. The company is headquartered in Chicago, Illinois. The company went IPO on 2021-10-21. The products and services that comprise its solution are designed to enable investment managers to take investment decisions in real time. The Company’s solution, comprised of mission critical systems integrated with a suite of technology-powered, managed services, serves the full investment lifecycle, drives insights into and control over the business activities of the investment manager and investment operations. Its solution’s end-to-end functionality includes Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System and Enfusion Analytics System. PMS able to comprehensively construct and re-balance investment portfolios, this system generates a real-time investment book of record. PMS module offers portfolio managers, traders, compliance teams and analysts the ability to electronically communicate trade orders.

Contact

ILLINOIS
Chicago
125 South Clark Street, Suite 750
+13122539800.0
https://enfusion.com/

IPO

2021-10-21

Employees

798

Officers

Interim CEO & Director
Mr. Oleg Movchan
Managing Partner
Mr. Stephen Malherbe
Chief Financial Officer
Mr. Stephen P. Dorton
Chief Operating Officer
Mr. Michael Berry
Chief Technology Officer
Mr. Daniel Groman
Investor
Mr. Brian Murphy
Show More
Chief Marketing & Communications Officer
Ms. Lorelei M. Skillman
Chief People Officer
Ms. Bronwen Bastone
MD of Managed Services Solutioning & Global Head of Client Services
Mr. Kabir Kohli
Global Head of Managed Services Production
Mr. Joseph Defeo
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one ENFN stock?

The intrinsic value of one ENFN stock under the Base Case scenario is 9.19 USD.

Is ENFN stock undervalued or overvalued?

Compared to the current market price of 9.41 USD, Enfusion Inc is Overvalued by 2%.